Abstract
Background With the advent of the novel coronavirus disease (COVID-19) and the severe second wave that caused high-profile deaths, hospitalization, and high treatment costs in Uganda, the population has raised concerns about the enactment of the national health insurance coverage bill.
As of March 31, 2021, when Uganda was beginning to experience the second wave of COVID-19, the Parliament of Uganda passed a national health insurance bill that outlined the general structure for the first national health insurance scheme. The bill had pre-set benefit packages including a wide range of essential health services such as family planning, vaccination, and counseling. The plan was proposed to be financed by a combination of employers and government contributions and aimed to cover all Ugandans when fully implemented. The policy and implementation details would evolve when the President enacts it into law. However, the President has not assented to the bill.
This study aimed to determine the prevalence of health insurance coverage and factors associated with COVID-19 vaccine acceptance among participants in northern Uganda and use findings to show its implications on Uganda’s achievement of Universal Health Coverage and Sustainable Development Goals.
Methods We conducted a cross-sectional study among seven hundred and twenty-three adult participants from northern Uganda. Participants were selected randomly and consecutively. We used a questionnaire with an internal validity of Cronbach’s a=0.772 to collect quantitative data from participants. A local IRB approved the study, and we used SPSS version 25.0 for data analysis. A p-value less or equal to 0.05 was considered significant.
Results The prevalence of health insurance coverage among the study population was low, 57/723(7.9%), with most insured 42/57(73.7%), accepting the COVID-19 vaccine with a mean age of 33.81 years SD+8.863 at 95% CI:31.46-36.16 and a median age of 35 years. Participants without insurance coverage but accepted the COVID-19 vaccine were 538/723(74.4%) with a mean age of 31.15 years SD+10.149 at 95% CI:30.38-31.92 and a median of 29 years. The insured and uninsured ages range from 18-52 years and 18-75 years, respectively. COVID-19 vaccine acceptance was higher among the insured 42/57(73.7%), and the likelihood ratio for insured participants to accept than reject the COVID-19 vaccine was 9.813; df=4; p=0.044. Widows, divorcees, and married separate, participants from remote districts (Nwoya and Lamwo), and those without formal education had no health insurance cover. However, in a multivariable logistic regression analysis, health insurance coverage was not an independent predictor of COVID-19 vaccine acceptance AoR=1.501,95%CI:0.807-2.791; p=0.199.
Conclusion As the world grapples with the control of COVID-19, vaccine acceptance and health insurance coverage have become critical issues to be handled by each country. The health insurance coverage among participants from northern Uganda was low at 57/723(7.9%). Most participants with health insurance coverage accepted the COVID-19 vaccines compared to those who did not. The lack of health insurance coverage among most study participants is problematic as the world looks toward attaining UHC and SDGs. We proposed that Uganda’s national social health insurance scheme, which is not legal, is urgently reviewed and signed to allow Uganda’s population access to the needed health services.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This is self-funded research with no financial link to any funding institution
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics approval and consent to participate: The St. Mary's Lacor Hospital Institutional and Ethics Committee (LHIREC) approved this study. In addition, the study followed the relevant institutional guidelines and regulations.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All datasets supporting this article's conclusion are within the paper and are accessible by a reasonable request to the corresponding author.
